Xencor stock hits 52-week high at 32.29 USD
Xencor Inc.'s stock recently reached a 52-week high of $32.29, currently trading at $32.83, indicating strong market performance and investor confidence with a 90.61% return over the past year. Truist Securities also raised its price target for Xencor to $29 from $27, maintaining a Buy rating ahead of an important update regarding XmAb819 at the ESMO event. Despite appearing overvalued by InvestingPro, these developments highlight potential growth prospects for the biotech company.
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.